Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 6/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.63 |
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.54 |
| ▸ | PNP | P00491 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TK1 | P04183 | 1/20 | 0.48 |
| ▸ | FPR2 | P25090 | 1/20 | 0.48 |
| ▸ | POLG | P54098 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5982928 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL207023 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL13262186 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL8345 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL5717505 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL24141674 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL7736439 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL12041986 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| SCHEMBL5982921 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1ALBLMNASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL8409010 | 0.95 | DNMT1 (0.58) | DNMT1ADRB1ALBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116539741-A | Method for detecting 5-fluorodeoxycytidine modified abundance in DNA (deoxyribonucleic acid) through LC-MS (liquid chromatography-mass spectrometry) | 中国农业科学院生物技术研究所 | 2023-08-04 | — | — | CN | disclosed |
| CN-108699546-B | Transposable element mobilization for enhancing genetic and epigenetic variability in a population | 巴塞尔大学 | 2022-06-07 | — | — | CN | disclosed |
| US-10184142-B2 | Biocatalytic production of nucleoside analogues as active pharmaceutical ingredients | PLASMIA BIOTECH, S.L. (ES) | 2019-01-22 | — | — | US | disclosed |
| US-20180352764-A1 | MOBILISATION OF TRANSPOSABLE ELEMENTS TO ENHANCE GENETIC AND EPIGENETIC VARIABILITY IN A POPULATION | UNIVERSITAT BASEL (CH) | 2018-12-13 | — | — | US | disclosed |
| CN-108699546-A | Transposable element mobilization for enhancing genetic and epigenetic variability in a population | 巴塞尔大学 | 2018-10-23 | — | — | CN | disclosed |
| US-20160076070-A1 | BIOCATALYTIC PRODUCTION OF NUCLEOSIDE ANALOGUES AS ACTIVE PHARMACEUTICAL INGREDIENTS | PLASMIA BIOTECH, S.L. (ES) | 2016-03-17 | — | — | US | disclosed |
| EP-2992107-A2 | BIOCATALYTIC PRODUCTION OF NUCLEOSIDE ANALOGUES AS ACTIVE PHARMACEUTICAL INGREDIENTS | Plasmia Biotech, S.L. (ES) | 2016-03-09 | — | — | EP | disclosed |
| WO-2014177585-A2 | BIOCATALYTIC PRODUCTION OF NUCLEOSIDE ANALOGUES AS ACTIVE PHARMACEUTICAL INGREDIENTS | PLASMIA BIOTECH, S.L (ES) | 2014-11-06 | — | — | WO | disclosed |